Harte-Hanks, Inc. Insider Trading Activity

Insider Trade Summary

Grant/Award: 25,000 shares

Grant/Award 3 txns

Insider GARRISON DAVID A

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	25,000	$4.55	$114K
holding	Option to buy Common Shares	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 25,000 shares (Indirect, Held by Harte Hanks until vested); Option to buy Common Shares — 64,600 contracts (Indirect, NQ stock options granted and held by Harte Hanks, Inc. until exercised.); Common Stock — 13,129 shares (Indirect, Shares held in participant's retirement account.)

Footnotes (4)

1. F1. Participant was granted 25,000 RSU shares on 6/02/2025 (contract signed on 7/03/25) which will vest in three equal tranches on the anniversary of the grant date over the following three consecutive years.
2. F2. Shares were purchased and held in participant's retirement account.
3. F3. 1/3 of options vests annually on January 29, beginning in 2025 and ending in 2027.
4. F4. Participant was granted 64,600 NQ stock options on 1/29/2024 that will vest 33% on the first three anniversaries of the grant date, 1/29/2025, 1/29/2026, and 1/29/2027.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/03/2025 - 01:09 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GARRISON DAVID A

(Last) (First) (Middle)

1 EXECUTIVE DRIVE SUITE 303

(Street)

CHELMSFORD MA 01824

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
HARTE HANKS INC [ HHS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/02/2025		A		25,000	A	$4.55	25,000(1)	I	Held by Harte Hanks until vested
Common Stock								13,129	I	Shares held in participant's retirement account.(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to buy Common Shares	$7.74							01/29/2025(3)	01/29/2034	Common Stock	64,600(4)		64,600	I	NQ stock options granted and held by Harte Hanks, Inc. until exercised.

Explanation of Responses:

1. Participant was granted 25,000 RSU shares on 6/02/2025 (contract signed on 7/03/25) which will vest in three equal tranches on the anniversary of the grant date over the following three consecutive years.

2. Shares were purchased and held in participant's retirement account.

3. 1/3 of options vests annually on January 29, beginning in 2025 and ending in 2027.

4. Participant was granted 64,600 NQ stock options on 1/29/2024 that will vest 33% on the first three anniversaries of the grant date, 1/29/2025, 1/29/2026, and 1/29/2027.

Remarks:

	/s/ Robert Wyman, Attorney-in-fact for David A Garrison	07/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.